Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/1/2025

Radiation Therapy Side Effects and Management

Introduction to Radiation Toxicities

  • Radiation pneumonitis typically occurs 2-6 months after treatment, with symptoms including nonproductive cough, exercise-induced dyspnea, low-grade fever, and chest pain, and is treated with oral prednisone, pentoxifylline, and symptomatic treatment, according to the Annals of Oncology 1
  • Cancer-related fatigue is a common symptom during cancer treatment, assessed using a 10-point Numeric Rating Scale, and has no specific drug therapy recommended, with psychostimulants, antidepressants, and acetylcholinesterase inhibitors showing no consistent benefit, as stated by the Annals of Oncology 1

Cardiovascular Late Effects

  • The American College of Cardiology recommends annual follow-up with ECG or echocardiogram as clinically indicated for patients who have received chest radiation, due to the increased risk of coronary artery disease, valvular disease, pericardial disease, and conduction abnormalities, with risk factors including hypertension, diabetes, dyslipidemia, and obesity 2
  • Radiation therapy is associated with an increased risk of cardiovascular disease, although there is no consensus on recommendations for cardiovascular screening, according to the American Heart Association 3

Genitourinary Late Effects

  • Urinary symptoms such as urgency, dysuria, and nocturia can be managed with symptomatic treatment, and vaginal stenosis can be treated with vaginal dilators, although compliance issues may limit effectiveness, as reported by Radiologia Medica 3
  • Genitourinary toxicity manifestations include urinary urgency, dysuria, nocturia, vaginal stenosis, with long-term use of vaginal dilators recommended for stenosis 4
  • The American Urological Association recommends management of genitourinary toxicity using symptomatic treatment for urinary symptoms, and surgical intervention may be required for urethral stricture 4
  • Vaginal stenosis occurs in some patients undergoing radiation therapy, and long-term use of vaginal dilators is indicated to reduce grade 2 late vaginal stenosis, although poor compliance may limit improvement, according to the American College of Obstetricians and Gynecologists 3

Bone Marrow and Soft Tissue Effects

  • Radiation can affect bone marrow stroma directly, increasing the risk of osteoporosis and fractures, with fibrosis of soft tissues also a potential late effect, according to the Annals of Oncology 5
  • Lymphopenia, granulocytopenia, and thrombocytopenia are common manifestations of hematologic toxicity, with a predictable decline in lymphocytes within 24-48 hours after exposure 6
  • The American Society of Hematology recommends management of hematologic toxicity using regular blood count monitoring, growth factors for severe cytopenias, and transfusion support as needed 6

Gastrointestinal Late Effects

  • Gastrointestinal toxicity manifestations include nausea, vomiting, diarrhea, abdominal pain, with a higher incidence during the first, second, and fifth weeks of treatment, and the first week post-treatment 6
  • The American Gastroenterological Association recommends management of gastrointestinal toxicity using antiemetics for nausea/vomiting, anti-diarrheals for loose stools, and dietary modifications 6
  • Recent studies suggest that the gut microbiome plays a role in determining gastrointestinal side effects, and routine follow-up visits should assess for GI symptoms during and after treatment, according to the European Society for Radiotherapy and Oncology 3
  • The National Comprehensive Cancer Network recommends that patients with gastrointestinal side effects undergo dietary modifications, although the strength of evidence for this recommendation is limited 3

Neurocognitive Late Effects

  • Neurocognitive dysfunction occurs in up to 90% of patients with brain metastases, and can be caused by direct tumor effects or treatment side effects, including surgery, radiation, chemotherapy, and immunotherapy, according to the American Academy of Neurology 7
  • The European Association of Neuro-Oncology recommends pharmacological approaches, such as donepezil, memantine, methylphenidate, and modafinil, as well as non-pharmacological approaches, including cognitive rehabilitation with compensatory strategies and "cognitive exercise" paradigms, to manage neurocognitive dysfunction, although the strength of evidence for these approaches varies 7
  • Radiation necrosis occurs in 0-30% of patients undergoing radiosurgery, and management algorithms should include initial observation if asymptomatic, glucocorticoids for symptomatic patients, and neurosurgical resection, laser interstitial thermal therapy, or bevacizumab if steroids fail or cause unacceptable side effects, according to the American Association of Neurological Surgeons 7

Skin Toxicity

  • Radiation dermatitis is a common side effect experienced by the majority of patients undergoing radiotherapy for cancer, particularly head and neck cancers, with mild to moderate dermatitis (grades 1-2) occurring in most patients and severe reactions (grade 3-4) occurring in 20-25% of patients, depending on total radiation dose, dose per fraction, overall treatment time, beam type and energy, and surface area of skin exposed 8
  • The American Society of Clinical Oncology recommends grading skin toxicity using a scale that includes mild erythema, dry desquamation (Grade 1), moderate erythema, patchy moist desquamation (Grade 2), confluent moist desquamation (Grade 3), and skin necrosis or ulceration (Grade 4) 8
  • Management of skin toxicity includes gentle washing with mild, unscented soap, moisturizers for Grade 1, and topical steroids, emollient creams, wound care for Grade 2-4 8

Treatment Planning and Patient-Specific Considerations

  • The National Comprehensive Cancer Network recommends limiting treatment duration to within 8 weeks to minimize toxicity, with careful planning to minimize exposure to normal tissues and adherence to dose constraints for organs at risk 9
  • The Annals of Oncology suggests that smoking cessation can decrease cough and dyspnea, exercise training may improve quality of life and restore functional capacity, and special attention should be given to patients with pre-existing conditions such as interstitial lung disease 1
  • The American Society for Radiation Oncology recommends careful treatment planning to minimize exposure to normal tissues, and the use of radioprotective agents for normal tissues 6
  • Intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), and image-guided radiotherapy (IGRT) can reduce the occurrence and severity of toxicity by improving precision, according to the American Society for Radiation Oncology 3
  • Patients should be informed about potential side effects before treatment, and specific preparation may be required, such as bladder filling or dietary recommendations, according to the National Comprehensive Cancer Network 3
  • Regular assessment of toxicities during treatment using specific grading scales, such as RTOG or CTCAE, and patient-reported outcome measures can help recognize and prevent acute toxicity, according to the European Society for Radiotherapy and Oncology 3
  • Long-term follow-up is necessary to monitor for late effects, and a multidisciplinary approach is recommended for management of complex late toxicities, according to the American Society for Radiation Oncology 3
  • The National Cancer Institute recommends awareness of the risk of second malignant tumors after radiation therapy 6
  • Hypothyroidism and hyperparathyroidism are potential side effects of radiation therapy, although the strength of evidence for these associations is limited 3

REFERENCES